Genetically engineered superantigens in experimental tumor therapy

Springer Seminars in Immunopathology

Volumn 17, Issue 4, 1996, Pages 397-410

  Antonsson, Per ^a   Hansson, Johan ^a   Kalland, Terje ^a,b   Lando, Peter A ^a   Ohlsson, Lennart ^a   Schad, Elinor ^b   Svensson, Anders ^b   Dohlsten, Mikael ^a,b  

^a Pharmacia Oncology Immunology   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

STAPHYLOCOCCUS ENTEROTOXIN; SUPERANTIGEN;

CANCER THERAPY; EXPERIMENTAL NEOPLASM; GENETIC ENGINEERING; PRIORITY JOURNAL; REVIEW;

ANIMALS; IMMUNOTHERAPY, ACTIVE; NEOPLASMS, EXPERIMENTAL; SUPERANTIGENS;

EID: 0029971238     PISSN: 03444325     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01795137     Document Type: Review

References (34)

1. Abrahmsén L, Dohlsten M, Segrén S, Björk P, Jonsson E, Kalland T (1995) Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J 14:2978
2. Acharya KR, Passalacqua EF, Jones EY, Harlos K, Stuart DI, Brehm RD, Tranter HS (1994) Structural basis of superantigen action inferred from crystal structure of toxic shock syndrome toxin-1. Nature 367:94
3. Betley MJ, Borst DW, Regassa LB (1992) Staphylococcal enterotoxins, toxic shock syndrome toxin and streptococcal pyrogenic exotoxins: a comparative study of their molecular biology. Chem Immunol 55:1
4. Dohlsten M, Hedlund G, Kalland T (1991) Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. Immunol Today 12:147
5. Dohlsten M, Hedlund G, Åkerblom E, Lando PA, Kalland T (1991) Monoclonal antibody-targeted superantigens: a different class of anti-tumor agents. Proc Natl Acad Sci USA 88:9287
6. Dohlsten M, Björklund M, Sundstedt A, Hedlund G, Samson D, Kalland T (1993) Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor Vβ3 transgenic mice. Immunology 79:520
7. Dohlsten M, Sundstedt A, Björklund M, Hedlund G, Kalland T (1993) Superantigen-induced cytokines suppress growth of human colon-carcinoma cells. Int J Cancer 54:482
8. Dohlsten M, Abrahmsén L, Björk P, Lando PA, Hedlund G, Forsberg G, Brodin T, Gascoigne NRJ, Förberg C, Lind P, Kalland T (1994) Monoclonal antibody-superantigen fusion proteins: tumor specific agents for T cell-based tumor therapy. Proc Natl Acad Sci USA 91:8945
9. Dohlsten M, Lando PA, Björk P, Abrahmsén L, Ohlsson L, Lind P, Kalland T (1995) Immunotherapy of human colon cancer by antibody targeted superantigens. Cancer Immunol Immunother 41:162
10. Dohlsten M, Hansson J, Ohlsson L, Litton M, Kalland T (1995) Antibody targeted superantigens are potent inducers of tumor infiltrating effector T lymphocytes in vivo Proc Natl Acad Sci USA 92:9791
11. Fischer H, Dohlsten M, Andersson U, Hedlund G, Ericsson P-O, Hansson J, Sjögren H-O (1990) Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human t cells. J Immunol 144:4663
12. Fraser JD, Urban RG, Strominger JL, Robinson H (1992) Zinc regulates the function of two super-antigens. Proc Natl Acad Sci USA 89:5507
13. Fraser JD, Lowe S, Irwin MJ, Gascoigne NRJ, Hudson KR (1993) Structural model of Staphylococcal enterotoxin A interactions with MHC class II antigens. In: Huber BT, Palmer E (eds) Current communications in cell and molecular biology, vol 7. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
14. Gidlöf C, Dohlsten M, Kalland T, Tötterman TH (1995) Antibodies are capable of directing superantigen-mediated T cell killing of chronic B-lymphocytic leukemia cells. Leukemia (in press)
15. Gjörloff A, Fischer H, Hedlund G, Hansson J, Kenney JS, Allsion AC, Sjögren HO, Dohlsten M (1991) Induction of interleukin-1 in human monocytes by the superantigen staphylococcal enterotoxin A requires the participation of T cells. Cell Immunol 137:61
16. + mononuclear leucocytes and freshly prepared leukemia cells. Cell Immunol 129:426
17. Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP (1991) Identitication of the staphylococcal enterotoxin A superantigen binding site in the beta I domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci USA 88:9954
18. Hudson KR, Tiedmann RF, Urban RG, Lowe SC, Strominger JL, Fraser JD (1995) Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med 182:711
19. Jardetzky TS, Brown JH, Gorga JC, Stern LJ, Urban RG, Chi YI, Stauffacher C, Strominger JL, Wiley DC (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711
20. Kalland T, Hedlund G, Dohlsten M, Lando PA (1991) Staphylococcal enterotoxin-dependent cell-mediated cytotoxicity. Curr Top Microbiol Immunol 174:81
21. Karp DR, Long EO (1992) Identification of HLA-DR1 β-chain residues critical for binding staphylococcal enterotoxin A and E. J Exp Med 175:415
22. Kotzin BL, Leung DY, Kappler J, Marrack P (1993) Superantigens and their potential role in human disease. Adv Immunol 54:99
23. Kraulis PJ (1991) MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Crystalogr 24:946
24. Lando PA, Dohlsten M, Ohlsson L, Kalland T (1995) Tumor-reactive superantigens suppress tumor growth in humanized SCID Mice. Int J Cancer 62:466
25. MacDonald HR, Lees RK, Baschieri S, Herrmann T, Lussow AR (1993) Peripheral T cell reactivity to bacterial superantigens in vivo: the response/anergy paradox. Immunol Rev 133:105
26. Mehindate K, Thihodeau J, Dohlsten M, Kalland T, Sekaly R-P, Mourad (1995) Crosslinking of two major histocompatibility complex class II molecules by a single SEA molecule is required tor proinflammatory cytokine gene expression. J Exp Med 182:1573
27. Mollick JA, Chintagumpala M, Cook RG, Rich RR (1991) Staphylococcal exotoxin activation of T-cells. Role of exotoxin-MHC class II binding affinity and class II isotype. J Immunol 146:463
28. Papageorgiou AC, Acharya KR, Shapiro R, Passalacqua EF, Brehm RD, Tranter HS (1995) Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure 3:769
29. Prasad GS, Earhart CA, Murray DL, Novick RP, Schlievert PM, Ohlendorf DH (1993) Structure of toxic shock syndrome toxin 1. Biochemistry 32:13761
30. Ren K, Bannan JD, Pancholi V, Cheung AL, Robbins JC, Fishetti VA, Zabriskie JB (1994) Characterization and biological properties of a new staphylococcal enterotoxin. J Exp Med 180:1675
31. Schad EM, Zaitseva I, Zaitsev VN, Dohlsten M, Kalland T, Schlievert PM, Ohlendorf DH, Svensson LA (1995) Crystal structure of the superantigen, staphylococcal enterotoxin type A. EMBO J 14:3292
32. Sundstedt A, Dohlsten M, Hedlund G, Höidén I, Björklund M, Kalland T (1994) Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology 82:117
33. Swaminathan S, Furey W, Pletcher J, Sax M (1992) Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801
34. Wallgren A, Festin R, Gidlöf C, Dohlsten M, Kalland T, Tötterman TH (1993) Efficient killing of chronic b-lymphocytic leukemia cells by superantigen-directed t cells. Blood 82:1230